Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease

NCT04339751 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Stopped Lack of enrollment.

Conditions

Cushing's Disease

Interventions

DRUG: Vorinostat

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)